
Cadila Healthcare Limited has informed the Exchange regarding a press release dated March 24, 2021, titled "Please find enclosed a copy of press release dated March 24, 2021 titled RemdacTM (Remdesivir) from Zydus now more affordable at Rs.899 .".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated March 24, 2021, titled "Please find enclosed a copy of press release dated March 24, 2021 titled RemdacTM (Remdesivir) from Zydus now more affordable at Rs.899 .".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences